The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

Small biotech companies encounter significant challenges in designing and implementing clinical development programmes. These companies have an even lower rate of success than that of large, ...

Researchers have found in a new study that Ultrasound remains a valuable first-line imaging tool for detecting urinary stones ...

Advances in instrumentation, modeling and control are more fully understood and utilized when assisted by first-principle, ...

The future of supply chain leadership lies in the intentional redesign of systems that combine human judgment with AI‑enabled ...

Meanwhile, inflation jitters have pressured Treasuries, and stocks look wobbly. If the conflict drags on, how much worse ...

TD Cowen 46th Annual Health Care Conference March 2, 2026 2:30 PM ESTCompany ParticipantsDave Gancarz - Chief Business ...

Hello, and welcome to the Lancashire Holdings Limited Full Year 2025 Results Conference Call. [Operator Instructions] On the call today, we have Alex Maloney, Group CEO; Natalie Kershaw, Group CFO; ...

A once-daily dose of a medication, which averaged 195 mg, produced blood levels significantly lower than those typically pursued by psychiatrists. However, it succeeded in generating a weak signal ...

Being first matters, and two decades of track record are not easily replicated. When an index hits all-time highs, the ...

Bermuda 0 Costa Rica 8 Bermuda coach Naquita Robinson insists that the only way the senior women’s national team will improve is by playing the best teams in the region after they were beaten ...

A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.